Arecor Therapeutics
Acquisition of Tetris Pharma and £6m equity raiseANGLE
£20m raise funds commercialisation through to mid-2024Allergy Therapeutics
Key data on track, return to growth expected next yearAvacta
AVA6000 set for third dose escalation stageRedx Pharma
All the ingredients for success now in placeRedx Pharma
Jazz Pharmaceuticals $5m milestone triggeredScancell
First Moditope oncology vaccine enters the clinicRedx Pharma
£34.3m raise extends runway through key data pointsArecor Therapeutics
AT278 hits the sweet spotANGLE
Parsortix FDA clearance marks a key transition point